Ivan Desviat
Ivan Desviat, MBA, CHCP is Director Medical Education Excellence for AbbVie biotech overseeing company led Medical Education strategic planning, implementation approach, and program impact measures for Medical Affairs across all company’s Therapeutic Areas at Global HQ and affiliates. He brings more than 20 years of documented success across a variety of Affiliate, EU Regional, US and Global assignments in Medical Affairs organization, Commercial teams and Continuous Performance roles.
Ivan is recognized for enhancing Medical Affairs internal capabilities such as scientific platforms, KOL engagement, insights, internal training and delivering educational engagement strategies with innovative programs in different local, regional, and global roles.
He has author several congresses oral, and posters related to medical education research and was granted in 2017 the prestigious GAME Medical Education international award for a PI program in collaboration with the health agency in Spain.
He recently accepted the role of Co-Chair of the MAPS External Education Focus Area Working Group. In this effort he will be working to enhance the value of Medical Affairs education within the industry while providing visibility to new approaches and solutions recently created in response to the changing landscape.
Ivan received the bachelor’s degree in industrial chemistry (M.Sc.) from the Universidad Complutense of Madrid (Spain), and was recipient of an Erasmus study grant to complete the Chemical Engineering degree (ChE) from the Ecole européenne de Chimie, Polymères et Materieu at Strasburg (France). He completed his MBA at Instituto de Empresa (IE), and holds a six sigma black belt and CHCP certification.
Heidi Anthoni
Heidi is based in Tokyo, Japan and leads the Oncology Medical Affairs Strategy for the Asia Pacific and South America region at Daiichi Sankyo. She is also a member of the MAPS focus area working group Medical Strategy & Launch Excellence. Heidi has 12 years’experience working in Medical Affairs in various roles across countries and therapeutic areas,and is passionate about developing innovative solutions for the benefit of patients, as well as driving change, building high-performing teams, and enhancing collaboration to bring out the best out of people and organizations. Before moving to Japan, Heidi was based in Germany as the Regional Medical Affairs Director at Daiichi Sankyo Europe, driving the medical strategy and launch excellence for Oncology indications. Heidi also has several years of field based Medical Affairs experience working with Amgen as well as Baxalta in Europe. Heidi holds a PhD in Molecular Biology from Karolinska Institute, Sweden, and an MBA from Helsinki School of Economics, Finland. She is a strong supporter of women in leadership and is also volunteering with the Healthcare Businesswomen’s Association as the Branch Lead for Asia-Pacific. She believes success is all about collaboration and joining forces, andtogether we can make an impact and transform the Medical Affairs profession to the next level.
張可佩
Kopei 於 2016 年 5 月加入安進，當安進在台灣建立醫藥部門時，領導公司產品的醫療策略、計劃和活動，並推動公司台灣同仁與區域和全球的連結與互動。 到2022 年， Kopei 已加入製藥產業在醫療事務方面擁有超過 13 年的經驗，擔任過醫藥顧問、臨床試驗、科學溝通、在藥廠不同領域的醫藥事務管理等各種角色，在之前已有急診醫學領域11 年的臨床經驗。
在加入安進之前，Kopei 於 2009 年 1 月至 2016 年 4 月在葛蘭素史克工作，擔任台灣地區醫藥顧問與醫藥處長，領導醫療事務、臨床運營和法規事務團隊。他帶領葛蘭素史克台灣完成醫藥互動模式的轉型。擔任醫藥顧問期間，他在台灣葛蘭素史克建立了一個科學溝通的團隊，並負責呼吸、免疫學、皮膚病學、神經科學、腫瘤學、代謝、感染領域提供專業協助。
1996年畢業於國立陽明醫科大學，獲得醫學學士學位，先後在林口長庚醫院接受急診醫學培訓，並在長庚醫院、衛福部基隆醫院、門諾基督教醫院從事急診與臨床治療與照護的工作。
